Miller Andrew Craig - Insider Non-Derivative Transactions at Karuna Therapeutics, Inc. (KRTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 18, 2024, Miller Andrew Craig's relationship to Karuna Therapeutics, Inc. (KRTX) is Officer (President of R&D), and currently has 9,412 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other KRTX insiders.
Data Source: SEC.
Miller Andrew Craig - Insider Non-Derivative Transactions of KRTX Common Stock
Miller Andrew Craig - Insider Non-Derivative Transactions at KRTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 19, 2024 | Disposition -- (Common Stock) | 9412 | 330 | 0 |
| Mar 19, 2024 | Disposition -- (Common Stock) | 13977 | 330 | 9412 |
| Feb 10, 2024 | F -- (Common Stock) | 1011 | 317.14 | 23389 |
| Apr 21, 2023 | Sell -- (Common Stock) | 15000 | 200.13 | 24400 |
| Apr 21, 2023 | M -- (Common Stock) | 8500 | 9.2 | 39400 |
| Apr 19, 2023 | Sell -- (Common Stock) | 30000 | 200.16 | 30900 |
| Apr 19, 2023 | M -- (Common Stock) | 30000 | 9.2 | 60900 |
| Feb 10, 2023 | Acquisition -- (Common Stock) | 12550 | 0 | 30900 |